Strychnine has been used for years as a medicinal remedy for a broad range of complaints. Strychnine is responsible for inhibiting postsynaptic glycine receptors, mostly in the spinal cord, causing painful, involuntary skeletal muscle spasms. Patients present with episodic muscle contractions with normal mental status and no post-ictal period. Treatment is mainly supportive with benzodiazepines and the management of complications from excessive muscle contractions. The following activity emphasizes the essential knowledge necessary for interprofessional teams to have while treating patients with strychnine toxicity.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/29584
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Chemical Pathology, Critical Care Medicine, Forensic Pathology, General Pediatrics, General Surgery, Hospital Medicine, Internal Medicine, Medical Toxicology, Neurocritical Care, Pediatric Emergency Medicine, Pediatric Neurology
Subscribe
Login
0 Comments
Oldest